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We surveyed a number of inbred mouse strains for susceptibility to meningococcemia. Mice of all strains
became bacteremic after intraperitoneal inj,ection of a serogroup C, serotype 2a human disease isolate, but the
strains differed in levels of bacteremia, indicating influences of the host genome on susceptibility. There was no
significant correlation between level of bacteremia and differences at major histocompatibility or immunoglob-
ulin loci; the Salmonella susceptibility locus, Ity; the complement CS locus, He; the antibody response locus,
xid; or the transferrin locus, Tr.f However, the Lps locus, which influences a range of host cellular responses
to endotoxin and affects susceptibility to Salmonella typhimurium, did influence susceptibility to meningococ-
cemia. There were significant differences in levels of bacteremia between C3H/HeJ (Lpsd) mice and each of the
other strains (all Lps"). We confirmed the association of the Lpsd genotype with susceptibility by using
coisogenic strains from two widely separated mouse lineages: C3H and B10. Lpsd mice experienced a 1,000-fold
proliferation of bacteria and were bacteremic for days before clearing the infection. In contrast, Lps' mice
cleared the bacteremia in less than 1 day. There was no difference in meningococcal growth in vitro in serum
from C3H/HeJ and coisogenic C3H/HeN (Lps") mice, suggesting that the Lps-related difference in susceptibility
may involve a cellular response.
Neisseria meningitidis is a gram-negative diplococcus that
is responsible for significant human disease. It is a leading
cause of bacterial meningitis in infants, young adults, and
closed populations such as military recruits, and it causes
frequent, severe epidemics in some parts of the world (4, 9).
Although the incidence of meningococcal disease in the
general population is low, the rapid course of the disease and
the significant morbidity and mortality associated with it
make it a public health hazard (4). In humans, the main
identified host susceptibility factor is deficient humoral im-
munity. The presence of bactericidal antibodies in serum is
associated with a low incidence of meningococcal disease (4,
8, 9). People with hereditary deficiencies of complement or
immunoglobulin and infants with physiologic hypoimmuno-
globulinemia are at relatively greater risk for the disease (4,
9, 24).
Mice have previously been used in the study of pathogen-
esis of and immunity to meningococcal disease (4, 13). After
intraperitoneal (i.p.) injection with virulent strains, mice
develop peritonitis and a transient bacteremia (4). Mouse
infection models have been used in immunoprotection stud-
ies (31) and in assessing the relative virulence of different
strains of meningococci (14), but consideration has seldom
been given to host factors contributing to susceptibility to
murine meningococcal infection. Host factors such as geno-
type influence the susceptibility of mice to a number of
pathogens (26). For example, the Lpsd allele of C3H/HeJ
mice is associated with increased susceptibility to infection
with Salmonella typhimurium (21) and Escherichia coli (12).
The Lpsd allele is also associated with decreased suscepti-
bility to endotoxin lethality and numerous defective re-
sponses of macrophages, B and T lymphocytes, and fibro-
blasts to stimulation with bacterial lipopolysaccharide (LPS)
(10, 20).
* Corresponding author.
To determine whether host genotype influences the sus-
ceptibility of mice to meningococcal infection and to try to
identify specific host variables influencing susceptibility, we
surveyed a number of inbred mouse strains and found that
significant differences in susceptibility were associated with
the Lps genotype of the host.
MATERIALS AND METHODS
Mice. All mice were obtained from Jackson Laboratory,
Bar Harbor, Maine, except for strains C3H/HeN (Charles
River Laboratories, Raleigh, N.C.) and C57BL/l0Sc (desig-
nated B10Sc) (Harlan/Sprague-Dawley Laboratory, India-
napolis, Ind.). The panel (Table 1) included strains of dis-
parate genotypes, and, in particular, strains varying at the
major histocompatibility locus, H-2; the immunoglobulin
heavy-chain locus, Igh-1; the Salmonella susceptibility lo-
cus, Ity; the complement CS locus, Hc; the X-linked immu-
nodeficiency locus, xid; the transferrin locus, Trf; and the
LPS response locus, Lps (10). Strains CBA/J and CBA/NJ
are coisogenic, differing at the xid locus (10). Strains C3HeB/
FeJ, C3H/HeN, and C3H/HeJ are essentially coisogenic,
differing at the Lps locus (7, 10), as are strains C57BL/10
(designated B10) and BlOSc (10). The Lps type (Lps' denot-
ing normal response and Lpsd denoting defective response)
of each of the C3H and B10 strains was confirmed by
endotoxin toxicity testing (19) (data not shown).
Female mice were used at 6 to 13 weeks of age. Mice used
in individual experiments were within 2 weeks of the same
age and generally had been kept in our animal facility for 1 to
2 weeks. All mice except strain BlOSc were specific patho-
gen free. In general, 4 to 10 mice of a strain and two or three
different mouse strains were used in each experiment. Mice
were housed in autoclaved, filtered cages and fed autoclaved
mouse chow, specially supplemented for autoclaving (Ral-
ston Purina Co., St. Louis, Mo.), and sterile water ad
libitum.
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TABLE 1. Inbred mouse strains used and alleles at selected locia
Alleles at following locus:
Mouse strain
H-2 Igh-J Ity Hc xid Trf Lps
A/J a e r 0
AKR/J k d r 0
BALB/cJ d a s 1
BUB/BnJ q a 1
CBA/J k j r 1 ab
CBA/NJ k i r 1 +C ab
C3H/HeJ k j r 1 dd
C3HeB/FeJ k j r 1
C3H/HeN k j r 1
C57BL/6J (B6) b b s 1
C57BL/1OSnJ b b s 1
(B10)
C57BL/l0ScCr b b s 1 dd
(B1OSc)
DBA/2J d c r 0
a H-2 is the major histocompatibility locus (10). Igh-J is the immunoglobulin
heavy-chain locus (10). Ity is a locus affecting susceptibility to S. typhimurium
and other pathogens (16). Hc is the locus for complement component C5
production (6). xid is the X-linked immunodeficiency locus (23). Trf is the
transferrin locus (10). Lps is a locus affecting responses to bacterial LPS (10,
20).
b Other strains are Tr.
c Other strains lack the xid genotype.
d Other strains are Lpsn.
Bacteria. The human disease isolate N. meningitidis
FAM18 (serogroup C, serotype 2a) was used.
Infection experiments. The methods for growing meningo-
cocci, intraperitoneal (i.p.) infection, and tail bleeding have
been described previously (31). Mice were injected with 1 x
102 to 6 x 102 CFU of log-phase meningococci in 500 ,ul of
phosphate-buffered saline (PBS), and levels of bacteremia at
various times after injection were determined by culturing
blood samples. In this way the course of the bacteremia in
individual mice could be monitored. The lower limit of
detection was 102 CFU/ml of blood. In initial experiments,
blood was cultured at 4, 8, and 12 h after injection. In other
experiments, blood was cultured at 4, 12, and 24 h after
injection and then at 24-h intervals until at least two consec-
utive negative blood cultures were obtained, after which
blood samples were no longer taken from that mouse for
culture. On rare occasions, mice were bacteremic after a
single negative blood culture.
Statistical methods. For each time point in the initial
experiments (4-, 8-, and 12-h bleedings), an analysis of
variance was performed to compare the average bacteremia
levels (log1o CFU/ml of blood) of each strain. Tukey's
studentized range test (27) with a simultaneous significance
level of 0.01 was used in comparing each pair of strain
averages. Thus, if in fact there is no difference, the proba-
bility of at least one comparison showing significance is 0.01
for the entire set of pairwise comparisons. In addition, a
linear contrast was used to compare the bacteremia levels of
all complement-sufficient (Hc') mice with those of the C5-
deficient (Hc°) mice. For these comparisons and for deter-
mination of the mean and standard error in the initial
experiments, the infrequent sterile blood cultures were as-
signed a value equal to the lower limit of detection (2.0). In
Fig. 1 and 2, the graphs of mean bacteremia level represent
the data only for mice that were bacteremic at a sampling
time.
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FIG. 1. Meningococcemia in C3H mouse strains. (A to C) Per-
centage of mice of strain C3HeB/FeJ (8 mice, panel A), C3H/HeN (8
mice, panel B), and C3H/HeJ (18 mice, panel C) bacteremic at
various times after i.p. infection with strain FAM18. The level of
detection was 102 bacteria per ml of blood. (D) Mean bacteremia of
bacteremic mice of the three strains at each of the time points, with
bars representing the standard error of the mean. The approximate
inoculum size is indicated by an arrow on the ordinate.
shown by colony blot radioimmunoassay (3) to express the
common pathogenic Neisseria H.8 antigen (3) and the two
class 5 outer membrane proteins of strain FAM18 (15) (data
not shown). Slide agglutination with N. meningitidis group C
antiserum (Difco Laboratories, Detroit, Mich.) confirmed
the expression of the capsular antigen of strain FAM18 by
the 9-day isolates. Using Western blot radioimmunoassay
(3), we detected immunoglobulin G antibodies against strain
FAM18 in a serum sample from a C3H/HeJ mouse after a
16-day bacteremia (data not shown).
Meningococcal growth in mouse serum. Log-phase men-
ingococci in GC broth (31) were mixed with an equal volume
of fresh mouse serum, incubated for 45 min with agitation at
37°C in a 5% CO2 atmosphere, and then plated on GC
medium base agar (Difco) for viable counts. Infant-rabbit
serum, which is not bactericidal for meningococci (32), was
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FIG. 2. Meningococcemia in B10 mouse strains. (A and B)
Percentage of mice of strain B10 (8 mice, panel A) and BlOSc (8
mice, panel B) bacteremic at various times after i.p. infection with
strain FAM18. The level of detection was 102 bacteria per ml of
blood. (C) Mean bacteremia of bacteremic mice of the two strains at
each of the time points, with bars representing the standard error of
the mean. The approximate inoculum size is indicated by an arrow
on the ordinate.
RESULTS
Meningococcemia in 10 inbred mouse strains. We chose 10
mouse strains representing different lineages with extensive
genotypic differences (Tables 1 and 2). A total of 8 to 19 mice
of each strain were infected i.p. with meningococcal strain
FAM18 and bled 4, 8, and 12 h later. The mean log1o levels
of bacteremia are listed in Table 2. All mice of all strains
were bacteremic at one or more of the sampling times,
except for 4 of the 19 C57BL/6 (designated B6) mice. Each
strain showed a maximum bacteremia at the 4- or 8-h
sampling times, except for strain C3H/HeJ, which showed a
maximum at 12 h. There was considerable variation in levels
of bacteremia in the different mouse strains at the three time
points. At the 4-h sampling time, 14 pairwise comparisons of
strains showed significant differences (P < 0.01) (Table 3).
However, none of these pairs of strains was significantly
different at both the 8- and 12-h sampling times, except for
TABLE 2. Level of bacteremia in mice of different strains at 4,
8, and 12 h after i.p. injection of meningococci
Mean bacteremia (loglo CFU/ml
No. of of blood)',b at following timesMouse strain mice after i.p. injectionc:
4 h 8 h 12 h
A/J 8 3.9 3.2 3.3
AKRIJ 8 2.7 2.6 2.4
BALB/cJ 8 3.3 3.8 2.4
BUB/BnJ 8 2.6 3.4 2.7
CBAIJ 8 3.1 2.9 2.0
CBA/NJ 8 3.7 3.9 2.4
C3H/HeJ 18 3.6 3.5 4.7
C3HeB/FeJ 8 3.0 2.9 2.2
B6 19 2.5 2.5 2.6
DBA/2J 11 3.6 3.9 2.2
a The standard error of the mean was -0.3 for each value.
b Sterile blood cultures were assigned a value of 2.0, equal to the lower limit
of detection.
c Meningococci were injected at 1 x 102 to 6 x 102 (102-0 to 102-8) CFU
(strain FAM18 was used).
the comparisons of strain C3H/HeJ with strains C3HeB/FeJ
and B6. Although several pairwise comparisons showed
significant differences at one of the three time points, there
was no readily apparent correlation between greater suscep-
tibility in this model with any of the loci shown in Table 1 at
the 4- and 8-h sampling times. However, there were signifi-
cant differences, of 1.4 to 2.7 orders of magnitude, between
strain C3H/HeJ (Lpsd) and each of the other nine strains (all
Lps') at the 12-h sampling time. The coisogenic strains
C3H/HeJ (Lpsd) and C3HeB/FeJ (Lps') differed significantly
at each of the sampling times: P = 0.01 at 4 h, P = 0.02 at 8
h, and P = 0.0001 at 12 h. C3H/HeJ mice also differed
significantly (P < 0.01) from B6 mice at each of the sampling
times. In all of these cases, C3H/HeJ mice experienced a
higher level of bacteremia than the other strains did. In
contrast, comparison of mice differing at the complement C5
locus Hc revealed a significant difference only at 4 h (P =
0.01, compared with P = 0.48 at 8 h and P = 0.32 at 12 h).
Meningococcemia in Lps coisogenic strains. In the initial
experiments, C3H/HeJ mice displayed a marked prolifera-
tion of bacteria in the blood at 12 h after infection. We
repeated the experiments, but continued to culture the blood
until mice were no longer bacteremic. We used three coiso-
genic strains differing at the Lps locus: C3H/HeJ (Lpsd),
C3HeB/FeJ (Lps'), and C3H/HeN (Lps'). After i.p. inocu-
lation, most mice of each strain became bacteremic, but
there were significant differences in the extent and duration
of bacteremia, which correlated with Lps type (Fig. 1).
Meningococci multiplied severalfold in mice of both Lps'
strains by 4 h after infection, but the mice were clearing the
bacteremia by 12 h and none was bacteremic at 2 days. The
mean and median durations of bacteremia for both Lps'
strains were <1 day. In contrast, greater meningococcal
proliferation (of approximately 3 orders of magnitude) oc-
curred in Lpsd C3H/HeJ mice by 12 h. In addition, the Lpsd
mice remained bacteremic for longer than the Lpsn mice did
before eventually clearing the infection. All C3H/HeJ mice
were bacteremic at 48 h, the mean and median durations of
bacteremia were both 6 days, and one mouse had a positive
blood culture at 16 days.
We tested whether the association of the Lpsd genotype
with susceptibility to prolonged, significant meningococce-
mia could also be detected in a different host genetic
background by using coisogenic B10 (Lpsn) and BlOSc
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TABLE 3. Pairwise comparison of levels of bacteremia of 10 mouse strains at three sampling timesa
Comparison with strain:
Mouse strain






CBA/N 1, 2 1
C3H/HeJ 3 1, 3 3 1, 3 3 3
C3HeB/FeJ 1 3b
B6 1 1, 2 1, 2 1, 2, 3
DBA12 3 1 1 3 1, 2
a The presence of a number in the table indicates that there was a statistically significant difference (P < 0.01) between two strains at a particular sampling time:
1, 4 h; 2, 8 h; 3, 12 h.
b p =0.01 at 4 h; P = 0.02 at 8 h; P = 0.001 at 12 h.
(Lpsd) mice. The results (Fig. 2) were essentially identical to
those for the C3H strains. Lps' mice were clearing the
bacteremia by 12 h after infection, and the mean and median
durations of bacteremia were both <1 day. Lpsd mice
experienced a 1,000-fold-higher bacteremia level at 12 h, and
the mean and median durations of bacteremia were both 6
days, with one mouse remaining bacteremic for 13 days. All
mice survived the infection.
Meningococcal growth in mouse serum. We wanted to
determine whether the difference in meningococcal growth
in vivo in Lps coisogenic mice was related to differences in
serum factors such as bactericidal antibody and complement
or transferrin. There was no detectable difference in growth
of strain FAM18 in vitro in serum from C3H/HeJ and C3H/
HeN mice (the doubling time was less than 45 min in 50%
serum from both strains), indicating that serum factors alone
did not account for the different susceptibilities of Lps
coisogenic mice.
DISCUSSION
Inbred mouse strains provide a valuable tool in under-
standing how genetically determined host factors influence
susceptibility to infectious diseases caused by a wide variety
of pathogens (26). Although mice have been used in the
study of N. meningitidis infection (4), there has been little
consideration of the possible effects of the differing host
genotypes used by different investigators. The mouse strains
we used in this study represented disparate genotypes and
varied at a number of loci known to influence susceptibility
to other pathogens, including the Ity locus (16), the xid
antibody production locus (23), and the complement C5
locus Hc (6). The mouse strains also varied at loci that could
be hypothesized to influence meningococcal infection. These
included Hc, since complement-mediated bactericidal activ-
ity is associated with immunity against meningococcal dis-
ease in humans (4, 8, 9, 24), and the transferrin locus, Trf,
since transferrin-mediated iron turnover has been implicated
as important in meningococcal infection in mice (13).
There were differences between some mouse strains in the
level of meningococcemia displayed after i.p. infection,
indicating that the host genotype influenced susceptibility.
These differences may indicate that susceptibility in this
model is polygenic, although minor differences in inoculum
size or metabolic state of the bacteria, as well as other host
or pathogen factors, could contribute to the differences we
observed. There was no significant correlation between the
level of meningococcemia in this model and particular alleles
at any of the loci described above or with major histocom-
patibility or immunoglobulin alleles.
In contrast, there were significant differences in suscepti-
bility associated with the Lps locus. Lpsd mice experienced
a longer duration of bacteremia than Lps' mice, as well as a
greater bacteremia level at 12 h. Although both C3HeB/FeJ
and C3H/HeN mice are frequently used as coisogenic rela-
tives ofC3H/HeJ mice (7, 12, 19, 21), these strains have been
separated for years, and there is at least one other locus
unrelated to Lps that varies between the strains, which is
responsible for Salmonella susceptibility in C3HeB/FeJ mice
(22). For this reason, we also confirmed our results by using
coisogenic strains from the B10 lineage. Susceptibility to
meningococcal infection completely correlated with the Lps
genotype in all the coisogenic mouse strains. More rigorous
proof of the role of the Lps locus in determining susceptibil-
ity or resistance to meningococcemia will require either
backcross linkage analysis or infection studies with appro-
priate recombinant inbred mice.
The Lps locus influences susceptibility to S. typhimurium
(21) and E. coli (12). Lpsd-mediated susceptibility to S.
typhimurium is caused by proliferation of the bacteria in the
reticuloendothelial system of the host as a result of dimin-
ished antibacterial activity of macrophages (21). Meningo-
coccal disease, which is typically rapid and fulminant and
against which humoral defenses are considered of primary
importance (4, 9), is very different from typhoid fever, which
is generally a more prolonged intracellular infection in which
cellular defenses are clearly important (21). Although the
evidence is not complete, the meningococcus is generally
considered an extracellular pathogen, unable to survive in
host immune cells (9, 25). We do not know whether Lps
determines the host response to pathogens that exploit the
host by very different mechanisms or whether a common
intracellular site of action influences the survival of meningo-
cocci as well as salmonellae.
Virtually all of the reported effects of the Lps locus
involve cellular responses (10, 20). Macrophages of Lpsd
mice show multiple defects, including decreased activation
in response to endotoxin (10, 20) and defective anti-Salmo-
nella activity (21). Lpsd macrophages are deficient in the
release of tumor necrosis factor and interferon in response to
LPS stimulation and are defective in tumoricidal activity and
in their response to macrophage migration inhibiting factor
(1, 10). The kinetics of polymorphonuclear leucocyte and
macrophage influx into the peritoneal cavity following the
injection of LPS is influenced by the Lps locus (19). B
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lymphocytes of Lpsd mice show reduced mitogenic stimula-
tion, polyclonal activation, and maturation in response to
LPS (10, 30).
Thus, it is likely that a cellular response to meningococcal
infection was influenced by the mouse locus Lps. Defects in
one or more of the above cell types could account for the
significant, prolonged meningococcemia we observed in
Lpsd mice. Although cell-mediated immunity in meningo-
coccal disease has not been as extensively studied as hu-
moral immunity, there is evidence for interactions between
some of these cell types and meningococci in human disease
and murine infection. Mononuclear cells are thought to play
a role in clearance and killing of circulating meningococci (5,
17). Meningococci cause a pyogenic infection, and polymor-
phonuclear leukocytes kill meningococci in vitro (25). Also,
some lymphocytes are meningococcidal (17), and meningo-
cocci and immunization with meningococcal antigens impair
the function of B and T lymphocytes (11, 18, 28, 29).
The defect we observed in Lpsd mice is unlikely to be
mediated by a difference in specific acquired antibody re-
sponse, since differences between Lps variant strains oc-
curred early (12 h) after infection, before any acquired
antibody response was detectable. The observation that
strain FAM18 meningococci grew equally well in serum from
Lps' and Lpsd mice also argues, albeit indirectly, that the
increased susceptibility of Lpsd mice to meningococcal in-
fection was not due to natural differences in serum factors
such as antibody, complement, or iron.
Lpsd_associated susceptibility to meningococcemia is not
unique to infection with strain FAM18, since some other
strains caused a bacteremia of even greater duration in C3H/
HeJ mice than that caused by strain FAM18 (our unpub-
lished data). However, some strains of meningococci were
cleared relatively rapidly in C3H/HeJ mice (our unpublished
data), indicating that there may be differences in the ability
of different meningococci to exploit the Lpsd genotype. We
are currently investigating possible differences in meningo-
coccal surface components that correlate with differences in
growth in C3H/HeJ mice. In murine typhoid fever, there is
also variation in the ability of different S. typhimurium
strains to exploit the Itys genotype (2).
Host susceptibility loci can have pleiomorphic effects. For
example, the murine locus Ity influences the killing of a
number of pathogens, including both procaryotes and eu-
caryotes and both intra- and extracellular pathogens (16).
We have shown that the murine locus Lps, which influences
cellular responses to endotoxin and susceptibility to S.
typhimurium, also affects susceptibility to N. meningitidis
infection. Coisogenic mice differing at the Lps locus may
provide a useful, well-defined genetic background with
which to study some aspects of resistance to meningococci
that have not been as well characterized as humoral immu-
nity.
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